J. Winck (Porto, Portugal), P. Paredi (London, United Kingdom)
Clinical phenotypic differences between COPD and asthma in elderly patients
B. A. Sin, S. Saryal, O. Akkoca, F. Oner, Z. Misirligil (Ankara, Turkey)
|  |
The association between polymorphic genotypes of glutathione s-transferases and COPD in Turkhis population
M. Calikoglu, L. Tamer, N. Aras, E. Ozgur, A. Kanik (Mersin, Turkey)
| |
Association of polymorphism of NAT2 gene and group factors of blood (ABO, MN, Gm) with risk of COPD
N. Khodzhayants, T. Ivtchik, E. Iantchina, T. Rodygina, M. Mitupova (St Petersburg, Russia)
| |
The use of probucol for correction of hydrolipoperoxidation disturbances in COPD patients who stopped smoking
D. D. Rackita, V. G. Makarova, V. Y. Garmash, D. R. Rackita (Ryazan, Russia)
| |
Systemic endothelial dysfunction in COPD patients – study on 60 cases
I. O. Agache, L. Eftimie, H. Rus, M. Radoi (Brasov, Romania)
| |
Relationship between endothelial haemostatic markers in patients with chronic obstructive pulmonary disease
O. M. Korzh (Kharkov, Ukraine)
| |
Studies on blood lymphocytes apoptosis in COPD patients
J. A. Mikryukova, G. L. Ignatova, L. A. Stepanisheva, E. V. Davydova, S. N. Teplova (Chelyabinsk, Russia)
| |
Disturbances of respiratory heat exchange in COPD
S. F. Agarkov, J. N. Chaliy, N. V. Sergienko, O. A. Khramova, D. J. Gurckevich (Donetsk, Ukraine)
| |
Can we use the evaluation of leukotriens in breath condensate for the diagnosis of chronic obstructive pulmonary disease (COPD)?
J. Musil, P. Cáp, F. Pehal (Prague, Czech Republic)
| |
The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
V. E. Valevich, A. E. Makarevich (Minsk, Belarus)
| |
IL8 as a marker of systemic inlammation in COPD
K. Busljetic, M. Boskova, B. Kaeva, C. Tatjana, O. Busljetic (Skopje, Macedonia)
| |
Some local markers indices of saliva inflammation in patients with COPD
L. A. Stepanisheva, G. L. Ignatova, S. N. Teplova (Chelyabinsk, Russia)
| |
Radiation-induced pathomorphosys of COPD in liquidatiors of Chernobyl catastrophe
V. A. Sushko, V. P. Tereshchenko, L. I. Shvayko, T. P. Segeda, A. S. Riazhska (Kyiv, Ukraine)
| |
Expression of inflammatory cytokines following stepwise dose reduction of corticosteroids of long-term oral corticosteroids users with COPD
D. Cotrim, R. Stelmach, M. C. Machado, M. P. T. Nunes, M. Ribeiro, M. M. P. Acencio, A. Cukier (Sao Paulo, Brazil)
| |
Sputum eosinophilia and the response to inhaled corticosteroid (mometasone) in COPD
C. Brightling, S. McKenna, B. Hargadon, R. Green, R. Siva, M. Berry, D. Parker, W. Monteiro, I. Pavord, P. Bradding (Leicester, United Kingdom)
| |
Increased oxidative stress and altered antioxidant status in Chinese patients with COPD
J. C. Mak, J. C. Ho, S. P. Ho, W. C. Yu, W. W. Yew, K. W. Tsang, W. K. Lam, M. S. Ip, M. M. Chan-Yeung (Hong Kong, China)
| |
Effects of glutation-S-transferase M1 (GSTM1) and T1 (GSTT1) and matrix metalloproteinase 9 (MMP9) on the decline of lung function in COPD patients
E. Iantchina, T. Ivtchik, N. Khodzhayants, M. Mitupova, A. Kokosov (St Petersburg, Russia)
| |
Genes of detoxication system, matrix metalloproteinase 9 (MMP9) and set of group factors of blood in the risk of development of COPD
T. Ivtchik, N. Khodzhayants, E. Iantchina, M. Mitupova, T. Rodygina, A. Kokosov, E. Schwartz (St Petersburg, Russia)
| |
Relationship between COPD and gastroesophageal reflux in liquidatiors of the Chernobyl catastrophe
E. A. Sarkisova, V. A. Sushko, A. S. Riazhska, G. A. Nezgovorova (Kyiv, Ukraine)
| |
The prevalence of low hemoglobin levels in patients with COPD stratified for disease stage
E. C. Creutzberg, A. Schilstra, R. Broekhuizen, E. F. M. Wouters (Horn, Maastricht, The Netherlands)
| |